The 12th Annual Innate Killer Summit brings together experts to discuss advancements in NK cell therapy, including preclinical and clinical developments, to address cancer, autoimmune diseases, and infectious conditions.
Key Topics
Applications of NK biology in tackling autoimmune diseases and infectious conditions
Developing engagers to recruit NK cells for anti-cancer activity
Maximizing NK expansion for scalable and effective allogeneic products
Clinical perspectives on NK therapy for autoimmune treatment
Optimizing strategies for genetic modification of NK cells
Leveraging combination approaches for enhanced NK therapy efficacy
Improving resistance of NK cells to the tumor microenvironment
Understanding the advantages of NK biology for future development
Optimizing cryopreservation to maintain NK cell viability and efficacy
Evaluating donor-derived versus iPSC-derived NK therapies
Accelerating NK therapy development with clear standards and regulatory expectations
Improving clinical NK performance for better patient outcomes
Lengthening NK cell persistence for prolonged therapeutic benefits
